Search

everythinglearnresearchcommunity

for

Search:↓

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

We need a safe, reliable way to stop severe hair loss.

Tofacitinib effectively and safely promotes hair regrowth in alopecia patients.

Tofacitinib significantly regrows hair in severe alopecia without major side effects.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Reduced Vitamin D receptor expression may cause hair loss through the Wnt/b-catenin pathway.

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

The 308-nm excimer laser helps hair regrowth in some alopecia areata cases but not all.

Most people with alopecia areata have nail changes, which are common but don't greatly affect their quality of life.

Almost half of the men with beard hair loss also developed scalp hair loss within a year.

Zinc supplementation may be an important part of treating severe hair loss.

Effective treatments for severe alopecia areata are still lacking.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Some patients with a type of skin lymphoma can experience a rare, non-scarring hair loss that looks like another hair loss condition but has distinct features.

Some patients with severe alopecia areata developed skin darkening from their treatment, which may indicate a less effective response to the therapy.

Alopecia areata causes patchy hair loss but hair can regrow on its own.

Salmon patches on the neck may relate to the severity and recurrence of alopecia areata.

Tofacitinib helped regrow hair in a woman with alopecia areata.

Combining nonablative fractional laser with minoxidil was effective for alopecia areata with only one patient relapsing after a year.

The study found that severe alopecia areata affects any age, treatments often give temporary results, and some factors predict worse outcomes.

Topical immunotherapy with DPCP is most effective for certain alopecia areata types, with success linked to age and disease duration, and influenced by a gene polymorphism.

Dupilumab helped a 4-year-old grow hair back after another treatment failed.

Alopecia totalis/universalis is a severe form of hair loss where all body hair is lost.

Current treatments for alopecia show no significant long-term benefits.

JAK inhibitors and platelet-rich plasma show promise for treating alopecia areata.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

The monkey's hair loss was due to an autoimmune disease, not genetics.